Tuesday 17 Jun, 2025 02:50 PM
Site map | Locate Us | Login
   Rane (Madras) jumps after board approves land sale in Velachery    DJ Mediaprint & Logistics Ltd leads losers in 'B' group    Volumes soar at Vishal Mega Mart Ltd counter    Brahmaputra Infra climbs after bagging Rs 24-cr orders from NHAI & WRD Assam    Aurobindo Pharma Ltd down for fifth straight session    Hindustan Zinc Ltd drops for fifth straight session    Balkrishna Industries Ltd drops for fifth straight session    Canara Bank slips for fifth straight session    ICRA revises long-term rating outlook of Paras Defence to 'positive'    NSE SME Jainik Power Cables trips on listing day    Gland Pharma Ltd gains for third consecutive session    Vishal Mega Mart drops after block deal    Allied Blenders' subsidiary introduces premium Russian vodka in India    Rajshree Polypack rises after bagging Rs 3-cr export order    Cinevista Ltd leads gainers in 'B' group 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Biocon launches QIP with floor price of Rs 340.20/share
17-Jun-25   09:49 Hrs IST

The company's board authorized and declared the opening of the issue on Monday, 16 June 2025.

The floor price of Rs 340.20 is at a discount of 4.79% to the scrip's previous closing price of Rs 357.30 on the BSE.

The company may offer a discount of not more than 5% on the floor price so calculated for the issue. The issue price will be determined in consultation with the book running lead managers appointed for the issue.

Biocon is an innovation-led global biopharmaceutical company focused on improving affordable access to complex therapies for chronic conditions like diabetes, cancer, and autoimmune diseases. It has developed and commercialized novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets, as well as generic formulations in the U.S. and Europe

The company's consolidated net profit surged 154.2% to Rs 344.50 crore on a 12.8% jump in net sales to Rs 4,358.10 crore in Q4 FY25 over Q4 FY24.

The scrip rose 0.78% to currently trade at Rs 360.10 on the BSE.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 42010657
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL Securities Private Limited